OPC.DEOPC.DEXETRA
Loading
EBITDA Over TimeStable
Percentile Rank57
3Y CAGR-19.9%
5Y CAGR+9.2%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-19.9%/yr
vs +24.4%/yr prior
5Y CAGR
+9.2%/yr
Recent deceleration
Acceleration
-44.2pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
3 yr
Consecutive declineStable
PeriodValueYoY Change
2025$11.36B-9.9%
2024$12.62B-11.4%
2023$14.24B-35.5%
2022$22.07B+60.3%
2021$13.77B+87.9%
2020$7.33B-21.9%
2019$9.39B+1.7%
2018$9.23B+77.6%
2017$5.20B+93.1%
2016$2.69B-